Feb 10, 2022, 14:09 by

‘Double Agent’ in Healthcare Industry Will Promote a Truly Patient-Centric Agenda Bracknell, UK - 3 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus will also be speaking at SCOPE 2022 on Thursday 10th February,11.30am ET, discussing how proper selection of healthcare providers for remote patient visits improves data integrity and monitoring. He will be sharing how the latest medical technologies meet patient care to create remarkable patient experiences, and the important factors to consider when selecting Healthcare Professionals for mobile health patient visits.

Feb 10, 2022, 14:09 by

At the SCOPE Summit (Feb 7-10, 2022), ClinOne will unveil its new brand, product marketecture, and messaging – and showcase how its mission to connect, inform and empower clinical trials patients is making it one of the fastest growing companies to watch in clinical technology.

Feb 10, 2022, 14:09 by

DFE Pharma appoints Martti Hedman as new CEO The combination of his experience, culture and drive makes him an ideal fit for DFE Pharma for the next stages of growth Goch, Germany (7th February 2022) – DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, today announced that Martti Hedman has been appointed as the new Chief Executive Officer. An experienced business leader, Hedman will succeed Bas van Driel and assume responsibilities on 14th February. Van Driel decided to step down in order to allow the company to further grow after setting the company up for success.

Feb 10, 2022, 14:09 by

Rho, a full-service contract research organization (CRO), is sharing its clinical development expertise with attendees of the 14th Annual Outsourcing in Clinical Trials (OCT) West Coast conference, taking place at the Hyatt Regency San Francisco Airport from February 15-16, 2022. Rho’s Associate Director of Business Development Brennan Munley is offering one-on-one meetings with those interested in learning more about how Rho can help ensure an efficient and a successful drug development process.

Feb 10, 2022, 14:09 by

A new Life Science and Clinical Research Job Board in the USA.

Feb 10, 2022, 14:09 by

Curebase Joins the SCRS Global Impact Partner Program

Feb 10, 2022, 14:09 by

Feb 10, 2022, 14:09 by

Novel Concepts Medical announces another major breakthrough in its research of COVID-19.

Feb 10, 2022, 14:09 by

RealTime Software Solutions, LLC has released the inSITES Report Builder, a powerful custom reporting tool built into RealTime’s leading Clinical Trial Management System (CTMS) that now allows all customers, at no additional charge, to build and save their own customized reports to monitor site-wide performance and maximize efficiencies and outcomes.

Feb 10, 2022, 01:00 by User Not Found

Clinical Research News | A 36-month PharmaLedger project sponsored by the Innovative Medicines Initiative and the European Federation of Pharmaceutical Industries and Associations is attempting to create a scalable blockchain platform with use cases for clinical trials as well as supply chain and health data. In the trials arena, the focus initially was on eConsent, but the public-private initiative is now intent on creating an end-to-end solution for clinical trial conduct, according to a report given yesterday at the Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida.

Feb 9, 2022, 01:00 by User Not Found

Clinical Research News | A fireside chat on what “fit-for-future” data operations might look like in a post-pandemic world was the topic of a keynote presentation on day two of the Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida yesterday. The risk-benefit ratio on many innovative methodologies and technologies has flipped over the past two years, elevating their value in the “new normal” moving forward, as shared by executives from a trio of leading biopharmaceutical companies.

Feb 8, 2022, 07:59 by User Not Found

Clinical Research News | Merck took first place honors at Participant Engagement Award ceremonies on the opening day of the Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida yesterday. Other honorees included Guardant Health and Tryl.

Feb 8, 2022, 01:00 by User Not Found

Clinical Research News | Autoimmune disorder treatments, AI-Based clinical prediction, cancer risk stratification, available funding for clinical efficacy research, and more.

Feb 4, 2022, 01:00 by User Not Found

Clinical Research News | It is no surprise that the global pandemic has created challenges in allowing trial sites to conduct research focusing on efficiency and quality care. However, it has also brought to the forefront the long-established systemic issues that site teams face in trial operations and related patient care and staff burdens. Ongoing issues such as increasing administrative responsibilities and timely patient onboarding make it difficult for site teams to focus more of their time on the bigger picture of high-quality patient care.

Feb 2, 2022, 01:00 by User Not Found

Clinical Research News | Trials are in line for treating mild cognitive impairment, inflammatory bowel disease, and MS; ObvioHealth announces a new ePRO offering; positive results for Renalytix risk monitoring tool in diabetic kidney disease study; acquisitions, mergers, and more.

Jan 31, 2022, 19:03 by

About Tower www.towercoldchain.com Tower delivers proven physical and temperature protection for pharmaceutical and life science products and our robust, reliable and reusable containers are the essential link in the stability of the cold chain. Headquartered in the UK, we operate a global network ensuring availability and easy access to our products for all customers. We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralised quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain. Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world. We work closely with our customers, realising their requirements and how we can address emerging needs. and to deliver customer-focused innovation in temperature-controlled protection. For Tower sales enquiries please contact: Nick Gilmore, Global Head of Sales & Marketing Email: Nick.Gilmore@towercoldchain.com For Tower media enquiries please contact: Simon Kinnear or Rhiannon Hopper, Nielsen McAllister Tel: +44 (0)1332 293939 Email: tower@nmpr.co.uk

Jan 31, 2022, 10:51 by User Not Found

Clinical Research News | Anyone who has ever played the game of telephone as a child knows only too well how a message can become completely scrambled by the time it passes through a succession of people. A similar type of communication breakdown can happen when a protocol gets communicated by a study sponsor to a contract research organization (CRO), and then handed off to study managers or monitors and ultimately clinical trial sites, especially for rare disease trials.

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Life sciences technology pioneer delivers record bookings and double-digit increase in revenue; Gears up for the future with investments in LifeSphere SaaS platform

Jan 28, 2022, 17:23 by